
Intelligent Biopharma is revolutionizing drug discovery and clinical development with AI-driven autonomous agents. Their platform accelerates the entire drug development lifecycle, from discovery and repurposing to licensing and competitive intelligence. Key products include IB Insights for weekly market intelligence, IB Knowledge Hub for curated disease and drug data, and IB Genius for building and deploying AI-driven multi-agent research teams that can operate 24/7. They also offer advisory services leveraging Real-World Evidence (RWE) and Multi-Agent Systems (MAS) to help clients optimize workflows, enhance research efficiency, and drive innovation. The company highlights metrics such as "95% Faster Development" and "$1B+ Investment Impact," suggesting significant value and efficiency gains for their clients.

Intelligent Biopharma is revolutionizing drug discovery and clinical development with AI-driven autonomous agents. Their platform accelerates the entire drug development lifecycle, from discovery and repurposing to licensing and competitive intelligence. Key products include IB Insights for weekly market intelligence, IB Knowledge Hub for curated disease and drug data, and IB Genius for building and deploying AI-driven multi-agent research teams that can operate 24/7. They also offer advisory services leveraging Real-World Evidence (RWE) and Multi-Agent Systems (MAS) to help clients optimize workflows, enhance research efficiency, and drive innovation. The company highlights metrics such as "95% Faster Development" and "$1B+ Investment Impact," suggesting significant value and efficiency gains for their clients.